Can You Take Mounjaro While On Statins? - Guide | Cured Pharmacy

Can You Take Mounjaro While On Statins?

Mounjaro Weight Loss Injections (Tirzepatide) KwikPen

Featured Product

Mounjaro Weight Loss Injections (Tirzepatide) KwikPen

From £145.00£124.99UK-based prescribers · Discreet delivery · Free private prescription
Start Assessment →✓ Lowest price guarantee
DISCOUNT CODE: FIRST20

£20 off for new patients

Tarun Kumar, Prescribing Pharmacist at Cured Pharmacy

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: 16 June 2026

Last Updated: 12 August 2026

If you have been prescribed Mounjaro for weight management or type 2 diabetes and you are already taking a statin for high cholesterol, you are likely wondering whether these two medicines are safe to use together. It is a very common question, and a completely valid one — because both medications affect your metabolism, your liver, and your cardiovascular health in meaningful ways. The short answer is that Mounjaro and statins can generally be taken together, but there are important nuances around monitoring, dose adjustments, and individual health factors that you should be aware of before starting or continuing either treatment.

Quick Summary

Mounjaro (tirzepatide) and statins are two medicines used for different but often overlapping health conditions — weight management or type 2 diabetes, and high cholesterol respectively. Understanding how they interact helps you stay safe and get the most benefit from both treatments.

  • Mounjaro and statins do not have a direct clinically significant drug-drug interaction in most patients.
  • Mounjaro slows gastric emptying, which may subtly affect how quickly statins are absorbed.
  • Significant weight loss from Mounjaro can improve your cholesterol profile, potentially reducing your statin requirement.
  • Regular blood tests including liver enzymes and lipid panels are recommended when using both medicines.
  • Always inform your prescriber about all medications you are taking before starting Mounjaro.

Mounjaro & Statin Interaction Checker

Answer a few quick questions to understand your personal risk level when combining Mounjaro with a statin. This is for informational purposes only — always consult your prescriber.

1. Which statin are you currently taking?

2. Have you experienced any muscle pain or weakness since starting Mounjaro?

3. Have you had liver enzyme blood tests in the past 6 months?

4. Has your GP reviewed your medications since starting Mounjaro?

Table of Contents

What Is Mounjaro and How Does It Work?

Mounjaro is the brand name for tirzepatide, a dual GIP and GLP-1 receptor agonist that was approved for use in the UK for weight management in adults with obesity or overweight with at least one weight-related health condition. It works by mimicking two hormones — glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) — that are naturally released after eating. By activating receptors for both of these hormones simultaneously, Mounjaro reduces appetite, slows gastric emptying, and improves blood sugar regulation in a way that other GLP-1 treatments alone cannot match.

Tirzepatide is administered as a once-weekly subcutaneous injection and comes in doses ranging from 2.5 mg up to 15 mg. Clinical trial data has demonstrated that patients using Mounjaro can lose on average 20% or more of their body weight over 72 weeks, making it one of the most effective weight loss treatments currently available through UK prescribers. Because of this significant metabolic impact, it can affect how your body processes other medicines, including statins.

  • Mounjaro mimics both GIP and GLP-1 hormones, making it a dual-action treatment.
  • It reduces appetite and slows digestion, which affects how quickly food and medicines are absorbed.
  • It is licensed in the UK for weight management and type 2 diabetes.
  • It is given as a weekly injection in gradually increasing doses.

What Are Statins and Why Are They Prescribed?

Statins are one of the most widely prescribed classes of medicines in the UK, taken by millions of people to lower LDL cholesterol (often called "bad cholesterol") and reduce the risk of cardiovascular events such as heart attacks and strokes. They work by inhibiting an enzyme called HMG-CoA reductase, which is responsible for producing cholesterol in the liver. By blocking this enzyme, statins reduce the amount of cholesterol the liver makes, which in turn encourages the liver to absorb more LDL cholesterol from the bloodstream.

Common statins prescribed in the UK include atorvastatin, simvastatin, rosuvastatin, and pravastatin. Atorvastatin is the most widely prescribed, largely because of its proven efficacy and favourable safety profile. Statins are generally taken once daily, and most people tolerate them well, though side effects such as muscle aches, fatigue, and digestive discomfort are sometimes reported. Given that many people with high cholesterol also have weight concerns or type 2 diabetes — the very conditions Mounjaro is used for — it is entirely unsurprising that a significant number of patients are using both treatments simultaneously.

  • Statins reduce LDL cholesterol by blocking an enzyme in the liver.
  • Atorvastatin, simvastatin, and rosuvastatin are among the most commonly prescribed in the UK.
  • Statins are a cornerstone of cardiovascular risk management.
  • Many statin users also have obesity or type 2 diabetes, conditions Mounjaro treats directly.

Can You Take Mounjaro While on Statins? The Interaction Explained

Can you take Mounjaro while on statins? Based on the current body of clinical evidence and pharmacokinetic research, yes — these two medicines can be co-administered for the vast majority of patients without causing a direct, harmful drug-drug interaction. Tirzepatide does not significantly inhibit or induce the cytochrome P450 enzyme system that is responsible for metabolising many statin drugs, which means it does not alter the core way in which statins are broken down in the body.

However, there is one important indirect mechanism to be aware of. Mounjaro significantly slows gastric emptying — the speed at which food and oral medicines pass from the stomach into the small intestine. This means that when you take a statin tablet at the same time as your meal or shortly before, it may be absorbed more slowly than usual during the early weeks of Mounjaro treatment. For most statins, this is unlikely to be clinically significant, but it is worth discussing with your prescriber or pharmacist, particularly if you are on a statin that has a narrow therapeutic window. This is why appropriate weight loss medical support is important when starting Mounjaro.

Statin Metabolism Route Known Interaction With Tirzepatide Clinical Significance
Atorvastatin CYP3A4 No direct pharmacokinetic interaction Low — monitor lipids periodically
Simvastatin CYP3A4 No direct interaction; absorption timing may shift Low to moderate — timing of dose may help
Rosuvastatin CYP2C9 (minor) No direct interaction reported Low — routine monitoring advised
Pravastatin Non-CYP (sulphation) No direct interaction Very low — generally well tolerated
Fluvastatin CYP2C9 No direct interaction identified Low — standard monitoring applies
  • There is no direct clinically significant drug-drug interaction between tirzepatide and any major statin.
  • Delayed gastric emptying from Mounjaro may slow statin absorption slightly.
  • This effect is generally more pronounced in the first few weeks of Mounjaro use.
  • Prescribers should be informed of all medicines to allow for appropriate monitoring.

How Mounjaro Affects Cholesterol and Your Statin Dose

One of the more clinically meaningful aspects of using Mounjaro alongside a statin is the effect that tirzepatide itself has on lipid profiles. Clinical trials, including the landmark SURMOUNT series, have demonstrated that tirzepatide not only reduces body weight but also improves multiple cardiovascular risk markers. Specifically, patients using Mounjaro have shown reductions in LDL cholesterol, significant reductions in triglycerides, and improvements in HDL (good) cholesterol levels. These changes are partly mediated directly through GIP and GLP-1 receptor activity, and partly through the downstream effects of substantial weight loss.

This creates an important clinical consideration for people taking statins alongside Mounjaro. As your lipid profile improves over the course of treatment — particularly if you lose a significant amount of weight — your GP may determine that you no longer need as high a dose of your statin, or in some cases, that you may eventually be able to stop the statin altogether under careful medical supervision. This is not a decision to make independently, but it is a realistic and positive outcome that many patients experience by 2026 following sustained Mounjaro use. Your prescriber will review your lipid levels at intervals and adjust your statin accordingly.

  • Mounjaro directly improves LDL cholesterol, triglycerides, and HDL cholesterol levels.
  • These lipid improvements come from both GLP-1/GIP receptor activity and weight loss itself.
  • Your statin dose may need to be reduced as your cholesterol levels improve.
  • Never reduce or stop your statin without specific instruction from your prescriber.
  • Regular lipid panel blood tests will guide any dose adjustments your GP recommends.

Monitoring and Blood Tests You Should Have

When you are taking both Mounjaro and a statin, proactive monitoring is essential. Statins are associated with a small risk of raised liver enzymes and, less commonly, myopathy (muscle damage), particularly at higher doses. Mounjaro, being processed through the liver and affecting metabolism in a significant way, means that keeping an eye on liver function is sensible for anyone on both medicines. Your GP or prescriber should be arranging liver function tests (LFTs) and a full lipid panel at regular intervals — typically every three to six months in the first year of Mounjaro treatment, and then annually thereafter if all results are stable.

It is also worth being vigilant about symptoms yourself. If you notice unexplained muscle aches, weakness, or dark-coloured urine whilst on a statin — particularly at higher doses — these can occasionally be signs of a rare but serious condition called rhabdomyolysis, where muscle tissue breaks down. Whilst Mounjaro does not increase this risk directly, the addition of any new medicine alongside a statin is a reasonable prompt to stay alert to your body's signals. Reporting any new or unusual symptoms promptly to your pharmacist or GP is always the right course of action. You can access expert advice through a registered UK weight loss medical service that can review your full medication list.

  • Liver function tests (LFTs) should be conducted regularly when using both medicines.
  • A lipid panel every three to six months helps track changes in your cholesterol profile.
  • Report any muscle pain, weakness, or dark urine to your GP without delay.
  • Blood glucose monitoring may also be relevant if you have type 2 diabetes.
  • Annual medication reviews are the minimum standard — request one if you have not had one recently.

Practical Tips for Taking Both Medicines Safely

Managing two medicines with different dosing schedules and mechanisms of action does not need to be complicated, but a few practical strategies can make the process smoother and safer. Most statins are taken once daily, and many patients take them in the evening, particularly simvastatin and atorvastatin. Mounjaro, by contrast, is a once-weekly injection. Because Mounjaro slows gastric emptying, there is some benefit in taking your statin at a consistent time each day, rather than changing the timing around your Mounjaro injection day. Consistency in timing helps maintain predictable statin levels in your bloodstream.

It is also important to maintain honest, open communication with every healthcare professional involved in your care. If you receive Mounjaro through a private prescriber or an online pharmacy and your statin is prescribed by your NHS GP, make sure both parties know about both medicines. In 2026, joined-up care is increasingly possible through shared care records, but you should never assume your GP knows about privately prescribed medications — always tell them. Keeping a simple list of all your medicines, doses, and prescribers on your phone or in your wallet can make consultations much more productive and safe.

  • Take your statin at a consistent time each day to maintain steady blood levels.
  • You do not need to avoid taking your statin on the same day as your Mounjaro injection.
  • Inform every prescriber — NHS and private — about all medicines you are taking.
  • Keep a written list of all your medications to share at every appointment.
  • Do not stop or reduce any medicine without professional advice, even if you feel better.

Key Takeaways

  • Mounjaro (tirzepatide) and statins can be safely co-prescribed in the vast majority of patients, with no direct pharmacokinetic drug-drug interaction identified.
  • Mounjaro's slowing of gastric emptying may mildly affect how quickly statins are absorbed, but this is generally not clinically significant for most patients.
  • Mounjaro itself improves cholesterol levels, which means your statin dose may need reviewing and potentially reducing over time as weight loss progresses.
  • Regular monitoring of liver function, lipid panels, and muscle-related symptoms is important when combining these medicines.
  • Always keep all your prescribers — NHS and private — fully informed about every medicine you are taking to ensure the safest possible care.

When to Seek Professional Advice

You should speak to your GP, prescriber, or pharmacist promptly if you experience any of the following whilst taking Mounjaro alongside a statin:

  • Unexplained muscle pain, tenderness, or weakness — particularly if it is widespread.
  • Dark-coloured urine, which may indicate muscle breakdown (rhabdomyolysis).
  • Nausea, vomiting, or jaundice (yellowing of the skin or eyes), which can signal liver problems.
  • A significant change in your cholesterol or blood sugar readings at your next blood test.
  • Any new symptoms that began after starting Mounjaro, even if they seem unrelated to your statin.

If you have not had a medication review since starting Mounjaro, booking one with your GP is strongly recommended. This is your opportunity to ensure your statin dose is still appropriate given the changes in your body weight, cholesterol levels, and metabolic health. Proactive medical care is always preferable to reacting to problems after they have developed.

Scientific References

  1. Electronic Medicines Compendium (EMC) — Mounjaro (tirzepatide) Summary of Product Characteristics. [Accessed 12 August 2026]
  2. National Institute for Health and Care Excellence (NICE) — Tirzepatide for managing overweight and obesity (TA1026). NICE, 2024. [Accessed 12 August 2026]
  3. British Heart Foundation — Statins: what you need to know. BHF, updated 2025. [Accessed 12 August 2026]
  4. NICE Guideline NG238: Cardiovascular disease: risk assessment and reduction, including lipid modification, NICE, 2023 [Accessed 12 August 2026]
  5. Mounjaro 5 mg solution for injection Summary of Product Characteristics, Eli Lilly, Electronic Medicines Compendium (EMC), 2023 [Accessed 12 August 2026]
  6. Tirzepatide monograph, British National Formulary (BNF), NICE, 2024 [Accessed 12 August 2026]
  7. Jastreboff AM et al., Tirzepatide Once Weekly for the Treatment of Obesity, New England Journal of Medicine, 2022 [Accessed 12 August 2026]
  8. Tirzepatide (Mounjaro): MHRA product information and regulatory approval summary, MHRA, 2023 [Accessed 12 August 2026]
  9. NICE Technology Appraisal TA924: Tirzepatide for managing overweight and obesity, NICE, 2024 [Accessed 12 August 2026]

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today.

Once you complete a short online assessment, you will be able to choose your preferred treatment and quantity from a list of safe, medically approved options tailored to you.

Start My AssessmentReturning Customer?Log In to Your Account

Frequently Asked Questions

Can you take Mounjaro while on statins safely?

Can you take Mounjaro while on statins safely? Yes, in most cases Mounjaro and statins can be used together safely. There is no direct pharmacokinetic interaction between tirzepatide and statin medicines. However, your prescriber should review your statin dose as Mounjaro-related weight loss may improve your cholesterol profile, potentially reducing the statin dose you need over time.

Can Mounjaro affect my statin absorption?

Mounjaro can affect statin absorption because it slows gastric emptying, which changes how quickly medicines move through your digestive system. This means statins taken orally may be absorbed more slowly when starting Mounjaro. For most patients this difference is clinically minor, but it is worth mentioning to your prescriber so they can monitor your response and adjust timing if needed.

Is it safe to take Mounjaro with atorvastatin?

Taking Mounjaro with atorvastatin is generally considered safe according to current UK clinical guidance. Atorvastatin is one of the most commonly prescribed statins and there is no known direct drug-drug interaction with tirzepatide. Your prescriber may monitor your liver enzymes and lipid levels periodically, particularly as your weight changes during Mounjaro treatment throughout 2026.

How long does Mounjaro take to affect cholesterol levels?

Mounjaro can begin affecting cholesterol levels within the first few months of treatment, with meaningful changes often seen after 12 to 24 weeks. Clinical trials have shown that tirzepatide reduces LDL cholesterol, triglycerides and improves HDL levels. As a result, your GP or prescriber may review your statin dose at your next medication review once significant weight loss has been achieved.

Back to blog